BRIGHT MINDS BIOSCIENCES INC (DRUG) Stock Earnings Estimates

NASDAQ:DRUG • CA10919W4056

77.9 USD
-2.67 (-3.31%)
At close: Feb 13, 2026
77.9 USD
0 (0%)
After Hours: 2/13/2026, 8:03:55 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
DRUG revenue by date.DRUG revenue by date.
EBITDA
YoY % growth
DRUG ebitda by date.DRUG ebitda by date.
N/AN/AN/A-14.967M-7.294M
51.26%		-2.74M
62.43%		-13.825M
-404.48%
EBIT
YoY % growth
DRUG ebit by date.DRUG ebit by date.
-78.7K-480.4K
-510.42%		-8.805M
-1,732.83%		-14.973M
-70.05%		-7.367M
50.80%		-2.814M
61.80%		-13.902M
-394.05%
Operating Margin
DRUG operating margin by date.DRUG operating margin by date.
N/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
DRUG eps by date.DRUG eps by date.
N/AN/AN/AN/AN/AN/AN/A

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A